Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27,691,200
-
Total 13F shares
-
11,346,536
-
Share change
-
-310,983
-
Total reported value
-
$49,924,524
-
Put/Call ratio
-
89%
-
Price per share
-
$4.40
-
Number of holders
-
26
-
Value change
-
-$2,427,096
-
Number of buys
-
11
-
Number of sells
-
15
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q4 2021
As of 31 Dec 2021 FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) had 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,346,536 shares of stock of the company.
Largest 10 holders included Southpoint Capital Advisors LP, Sonic Fund II, L.P., Avoro Capital Advisors LLC, DG Capital Management, LLC, Solas Capital Management, LLC, 683 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, HARBERT FUND ADVISORS, INC., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and BlackRock Inc..
This table shows 26 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.